| 產品編號 | 圖片 | CAS No. | 名稱及描述 | 規格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 201083-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(2-萘基)螺環二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C41H35O4P | |
| 201082-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(2-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C41H35O4P | |
| 201082-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(2-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C41H35O4P | |
| 201082-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(2-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C41H35O4P | |
| 201081-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C41H35O4P | |
| 201081-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C41H35O4P | |
| 201081-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C41H35O4P | |
| 201080-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C41H35O4P | |
| 201080-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C41H35O4P | |
| 201080-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二(1-萘基)螺環二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-1-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C41H35O4P | |
| 201079-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C37H39O4P | |
| 201079-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C37H39O4P | |
| 201079-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aS)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C37H39O4P | |
| 201078-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C37H39O4P | |
| 201078-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C37H39O4P | |
| 201078-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙(3,5-二甲基苯基)螺環二酚磷酸酯 (11aR)-3,7-Bis(3,5-dimethylphenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C37H39O4P | |
| 201077-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C37H27F12O4P | |
| 201077-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C37H27F12O4P | |
| 201077-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環二酚磷酸酯 (11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C37H27F12O4P | |
| 201076-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C37H27F12O4P | |
小泰
|
010-60710855
|